Beatriz Arrizabalaga
Barakaldo, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients.
Journal: The pharmacogenomics journal
Published: August 12, 2019
Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies.
Journal: Journal of medical genetics
Published: May 02, 2019
Autoimmune haemolytic anaemias: A retrospective study of 93 patients.
Journal: Medicina clinica
Published: January 31, 2019
Liver iron concentration in dysmetabolic hyperferritinemia: Results from a prospective cohort of 276 patients.
Journal: Annals of hepatology
Published: January 10, 2019
Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group.
Journal: Leukemia research
Published: July 02, 2017
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).
Journal: American journal of hematology
Published: March 13, 2017
Phenotype of mutations in the promoter region of the β-globin gene.
Journal: Journal of clinical pathology
Published: February 02, 2017
Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload.
Journal: Clinical biochemistry
Published: January 16, 2017
Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 07, 2016
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: April 06, 2016
Last Updated: 09/26/2026